Armata Pharmaceuticals
ARMP
ARMP
23 hedge funds and large institutions have $3.85M invested in Armata Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.27% more ownership
Funds ownership: 3.28% → 3.55% (+0.27%)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$236K | |
| 2 | +$121K | |
| 3 | +$93.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.74K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$6.57K |
Top Sellers
| 1 | -$99.9K | |
| 2 | -$22K | |
| 3 | -$14.7K | |
| 4 |
BlackRock
New York
|
-$4.17K |
| 5 |
JPMorgan Chase & Co
New York
|
-$169 |